Render Target: SSR
Render Timestamp: 2025-03-20T20:08:36.275Z
Commit: 779953b12a5930618aae6aca7c87fb286faeb1d7
XML generation date: 2025-03-07 13:12:48.259
Product last modified at: 2025-02-07T08:01:02.172Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Antibody Sampler Kit
PDP - Template ID: *******4a3ef3a

Initiator Caspases Antibody Sampler Kit #12675

    Product Information

    Product Description

    The Initiator Caspases Antibody Sampler Kit provides an economical means of evaluating initiator (apical) caspase proteins. The kit contains enough primary antibody to perform two western blots with each primary antibody.

    Background

    Apoptosis is a regulated physiological process leading to cell death. Caspases, a family of cysteine acid proteases, are central regulators of apoptosis. Initiator caspases (including 2, 8, 9, 10 and 12) are closely coupled to proapoptotic signals, which include FasL, TNF-α, and DNA damage. Once activated, these caspases cleave and activate downstream effector caspases (including 3, 6 and 7), which in turn cleave cytoskeletal and nuclear proteins such as PARP, α-fodrin, DFF and lamin A; inducing apoptosis (1,2).
    Formation of a death-inducing signaling complex (DISC) around the receptors for death factors, including FasL and TNF-α, is essential for receptor-mediated apoptosis (3). Upon ligand activation, Fas and TNF-R1 associate with death domain (DD) containing adaptor proteins FADD (Fas associated death domain) (4,5) and TRADD (TNF-R1 associated death domain) (6). In addition to a carboxy-terminal DD, FADD contains an amino-terminal death effector domain (DED) that binds to DEDs and activates initiator caspase 8 (FLICE, Mch5, MACH) and caspase 10 (FLICE2, Mch4) (7-12). TRADD does not contain a DED and therefore must associate with FADD in response to TNF-R1 driven apoptosis (13).
    Caspase-9 (ICE-LAP6, Mch6) is activated through the mitochondrial-mediated pathway. Cytochrome c released from mitochondria associates with procaspase-9 (47 kDa)/Apaf-1. Apaf-1 mediated activation of caspase-9 involves proteolytic processing resulting in cleavage at Asp315 and producing a p35 subunit. Another cleavage occurs at Asp330 producing a p37 subunit that can amplify the apoptotic response (14-17).
    Caspase-2 (Nedd2/ICH-1) is the nuclear apoptotic respondent to cellular genotoxic stress or mitotic catastrophe. The procaspase is cleaved at Asp316, producing a 14 kDa fragment and a 32 kDa prodomain/large subunit. Subsequent processing at Asp152 and Asp330 produces an 18 kDa large subunit and a 12 kDa small fragment (18). Activation occurs upon recruitment to a complex containing a p53-induced death domain protein, PIDD (19). This suggests that caspase-2 can be a nuclear initiator caspase with a requirement for caspase-9 and caspase-3 activation in downstream apoptotic events (20,22). In apoptotic pathways resulting from UV-induced DNA damage, processing of caspase-2 occurs downstream of mitochondrial dysfunction and of caspase-9 and caspase-3 activation, extending a possible role for caspase-2 as a parallel effector caspase (22).
    Caspase-3 (CPP-32, Apoptain, Yama, SCA-1) is a critical executioner of apoptosis and caspase-3 cleavage is a key indicator of initiator caspase activation. Caspase-3 is either partially or totally responsible for the proteolytic cleavage of many key proteins including the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (23). Activation of caspase-3 requires proteolytic processing of its inactive zymogen into activated p17 and p12 fragments (24).
    1. Budihardjo, I. et al. (1999) Annu Rev Cell Dev Biol 15, 269-90.
    2. Cohen, G.M. (1997) Biochem J 326 ( Pt 1), 1-16.
    3. Nagata, S. (1997) Cell 88, 355-65.
    4. Chinnaiyan, A.M. et al. (1995) Cell 81, 505-12.
    5. Boldin, M.P. et al. (1995) J Biol Chem 270, 7795-8.
    6. Hsu, H. et al. (1995) Cell 81, 495-504.
    7. Muzio, M. et al. (1996) Cell 85, 817-27.
    8. Boldin, M.P. et al. (1996) Cell 85, 803-15.
    9. Vincenz, C. and Dixit, V.M. (1997) J Biol Chem 272, 6578-83.
    10. Fernandes-Alnemri, T. et al. (1996) Proc Natl Acad Sci U S A 93, 7464-9.
    11. Kischkel, F.C. et al. (2001) J Biol Chem 276, 46639-46.
    12. Wang, J. et al. (2001) Proc Natl Acad Sci U S A 98, 13884-8.
    13. Hsu, H. et al. (1996) Cell 84, 299-308.
    14. Liu, X. et al. (1996) Cell 86, 147-57.
    15. Li, P. et al. (1997) Cell 91, 479-89.
    16. Zou, H. et al. (1999) J Biol Chem 274, 11549-56.
    17. Srinivasula, S.M. et al. (1998) Mol Cell 1, 949-57.
    18. Li, H. et al. (1997) J Biol Chem 272, 21010-7.
    19. Tinel, A. and Tschopp, J. (2004) Science 304, 843-6.
    20. Dirsch, V.M. et al. (2004) Oncogene 23, 1586-93.
    21. Castedo, M. et al. (2004) Oncogene 23, 4362-70.
    22. Paroni, G. et al. (2001) J Biol Chem 276, 21907-15.
    23. Fernandes-Alnemri, T. et al. (1994) J Biol Chem 269, 30761-4.
    24. Nicholson, D.W. et al. (1995) Nature 376, 37-43.
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.